Ross Kedl, PhD

Professor of Immunology & Microbiology
University of Colorado

Ross KedlDr. Kedl received his PhD in 1997 in the Department of Laboratory Medicine and Pathology at the University of Minnesota in Minneapolis. Before joining the Faculty at the University of Colorado, Dr. Kedl was at 3M Pharmaceuticals working in their small molecule immune response modifier program. In his three years there, he spearheaded efforts at developing novel vaccine adjuvants, resulting in numerous publications and patents in the area of vaccine technology. Dr. Kedl returned to the academic sector in 2004 by joining the faculty in the Integrated Department of Immunology at the University of Colorado Health Sciences Center and National Jewish Medical Research Center where he continues to pursue the discovery and development of novel and clinically applicable vaccine technology. He is also the founder of a start-up pharmaceutical company, ImmuRx Inc., which focuses on developing therapeutic vaccines against chronic infectious diseases, such as HIV and cancer.

Biography from University of Colorado.

IDIGH Calendar

<<  <  July 2021  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
     1  2  3  4
  5  6  7  8  91011
12131415161718
19202122232425
262728293031 

Latest IDIGH Publications

  1. El-Zein, M., Gotlieb, W., Gilbert, L., Hemmings, R., Behr, M. A., Franco, E. L. & STAIN-IT study group.
    (2020)
    .
    Dual staining for p16/Ki-67 to detect high-grade cervical lesions: results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing (STAIN-IT) study
    .
    International journal of cancer
  2. Hoenigl, M., Lin, J., Finkelman, M., Zhang, Y., Karris, M. Y., Letendre, S., Ellis, R. J., Burke, L., Richard, B., Gaufin, T., Isnard, S., Routy, J.-P. & Gianella, S.
    (2020)
    .
    Glucan rich nutrition does not increase gut translocation of Beta glucan
    .
    Mycoses
  3. Dallmann-Sauer, M., Fava, V. M., Gzara, C., Orlova, M., Van Thuc, N., Thai, V. H., Alcaïs, A., Abel, L., Cobat, A. & Schurr, E.
    (2020)
    .
    The complex pattern of genetic associations of leprosy with HLA class I and class II alleles can be reduced to four amino acid positions
    .
    PLoS pathogens
    ,
    vol
    .
    16
    ,
    p
    .
    e1008818
    .
  4. Montresor, A., Mupfasoni, D., Mikhailov, A., Mwinzi, P., Lucianez, A., Jamsheed, M., Gasimov, E., Warusavithana, S., Yajima, A., Bisoffi, Z., Buonfrate, D., Steinmann, P., Utzinger, J., Levecke, B., Vlaminck, J., Cools, P., Vercruysse, J., Cringoli, G., Rinaldi, L., Blouin, B. & Gyorkos, T. W.
    (2020)
    .
    The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030
    .
    PLoS neglected tropical diseases
    ,
    vol
    .
    14
    ,
    p
    .
    e0008505
    .
  5. Milic, J., Menozzi, V., Schepis, F., Malagoli, A., Besutti, G., Franconi, I., Raimondi, A., Carli, F., Mussini, C., Sebastiani, G. & Guaraldi, G.
    (2020)
    .
    Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
    .
    AIDS (London, England)
More publications